Search results
Poorer English Breast Cancer Survivors Face Higher Second Cancer Risk
Forbes· 17 hours agoBreast cancer survivors are more likely to develop a second form ofcancer if they live in the...
Breast cancer survivors have higher risk for other cancers
UPI· 3 days agoFemale breast cancer survivors were found to have an 87% higher odds of developing endometrial ...
Young breast cancer survivors almost twice as likely to develop another cancer, study finds
The Telegraph via Yahoo News· 4 days agoThe study also found men surviving breast cancer were 55 times more likely than the general male...
People with breast cancer more likely to develop second cancer over time, study finds
CBS News· 3 days agoA new study finds that people with breast cancer are more likely to develop a second cancer over...
Study highlights increased risk of second cancers among breast cancer survivors
Medical Xpress· 4 days agoSurvivors of breast cancer are at significantly higher risk of developing secondcancers, including...
Symptoms of uterine cancer after menopause
Medical News Today· 6 days agoA person may also experience pelvic pain, unintentional weight loss, and the feeling of a mass in the pelvis in later stages. Risk factors for uterine ...
Secondary cancer: Why breast cancer survivors have a higher risk
Medical News Today· 4 days agoHaving had breast cancer increases women’s as well as men’s risk of a second cancer later by around 25%, according to research. In addition ...
Fashion show celebrates 24 people living with and beyond breast cancer
Press Association News via AOL· 2 days agoMark Winter, one of the two male models at the Breast Cancer Now fashion show (Shivansh Gupta/PA) Mr...
Cancer survivors from poorer places at higher risk of second cancer
KTBS Shreveport· 3 days agoBreast cancer survivors from more deprived areas are at a far higher risk of developing a second ...
Europe Recommends Three Cancer Drugs
Medscape· 3 days agoThe European Medicines Agency has recommended Fruzaqla, Truqap, and Eribulin Baxter for use in the treatment of specific colorectal and breast cancers.
